Antares Pharma
Minneapolis
About Antares Pharma
Antares Pharma is a revenue-generating product-focused specialty pharmaceutical company that has developed three proprietary platforms, two of which now include FDA-approved products. Its products typically improve safety and efficacy profiles by minimizing dosing and reducing side effects while improving patient compliance. It focuses on self-injection pharmaceutical products and technologies and topical gel-based products. Its subcutaneous injection technology platforms include Vibex disposable pressure-assisted auto-injectors, Vision reusable needle-free injectors, and disposable multi-use pen injectors.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $45.0M
- Funding stage: M&A
- Last round: Post-IPO Debt (Jun 2017)
- Ticker: fra:MJC
- Website: antarespharma.com
- Phone: 7634761009
Industries & Categories
Health Care, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/antares-pharma-161869 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.